This federal contract award was issued by the Defense Logistics Agency (DLA) on July 10, 2024 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $18,568.80 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML syringes, with a contract period of performance through July 31, 2024.
DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of Department of Defense healthcare facilities through this IDC vehicle, solidifying the company's position as a key supplier in the federal pharmaceutical supply chain.
Generated 1/9/25, 9:08 AM